miRNA-6236 调节后血性骨肌血管生成的调节
Arul M Mani1, Victor Lamin1, Ronan C Peach1
1Division of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IA USA.
Journal of the American Heart Association
|November 27, 2024
概括
一种新的微RNA,miR-6236,在外周动脉疾病中升高. 抑制miR-6236可以改善血流恢复和缺血后血管形成.
科学领域:
- 分子生物学分子生物学
- 心血管研究研究心血管研究
- 遗传学 遗传学 是一个
背景情况:
- 周围动脉疾病 (PAD) 影响全球超过2亿人,其特点是肢体血流减少.
- 目前对PAD的治疗方法有限,这凸显了对新型治疗点的需求.
- 一个新发现的微RNA,miR-6236,在缺血性四肢组织中被发现是高调的.
研究的目的:
- 研究miR-6236在周围动脉疾病 (PAD) 中的作用及其对血管生成的影响.
- 为了确定miR-6236在缺血条件下对内皮细胞功能的影响.
- 评估针对miR-6236的治疗潜力,以改善PAD的输液恢复.
主要方法:
- 在实验室模型中使用初级人类和小鼠内皮细胞暴露于模拟缺血.
- 开发了miR-6236淘汰赛小鼠,以评估其 in vivo 的功能.
- 采用小鼠后肢缺血模型来评估后缺血输液恢复.
- 进行生物信息学和基因表达分析以确定miR-6236的目标.
主要成果:
- 模拟性缺血增加了内皮细胞中的miR-6236表达;其抑制增强了细胞活力,迁移和管形成,同时减少了细胞亡.
- 在糖尿病PAD模型中,miR-6236淘汰赛小鼠表现出改善的输液恢复和血管生成.
- 六个预测的血管性向mRNAs显示出与缺血肌肉中miR-6236调节一致的表达模式.
结论:
- miR-6236是后血性血管生成和外周动脉疾病中的 perfusion 恢复的关键调节剂.
- 向miR-6236为增强PAD血管修复提供了一个有希望的治疗策略.
- 这项研究阐明了PAD血管功能障碍背后的新型分子机制.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K